glp 1 patch effectiveness GLP-1 patches are worse than you think (I was wrong) Do GLP-1 Patches Work​?

For analysis of the mitochondrial respiratory chain complexes I, II and IV, a quadruple immunofluorescence method (MITIF) was applied [1]

(2021), Lancet 397(10286), PubMed 33894838 Statistics from preclinical literature Cagrilintide (development code AM833 ), a long-acting amylin analogue , 32 amino acids, molecular weight 3.795 kDa Developed at Novo Nordisk (Denmark) as part of the CagriSema combination program (cagrilintide + semaglutide) Target: amylin receptors (AMY1, AMY2, AMY3) + secondarily the calcitonin receptor , extended half-life via a C16 fatty acid linker Standard dose in clinical trials: 0.164.5 mg/week subcutaneously (Phase 1b/2) Phase 2 (Enebo 2021, n=96): 17.1 % reduction in body weight with CagriSema 2.4 mg + 2.4 mg over 20 weeks vs 9.8 % with semaglutide alone REDEFINE 1 Phase 3 (2024, preliminary data): 22.7 % weight reduction with CagriSema 2.4 mg/2.4 mg over 68 weeks Status: Phase 3 completed 20242025 , FDA filing expected 20252026 Approximately 25+ peer-reviewed publications in PubMed (20182024) Reference sources (PubMed) Enebo LB

Lets explore this treatment from a relatable, first-person perspective

Overall, participants are not meeting the daily servings for fruit, vegetables, grains, or dairy food group recommendations based on self-reported servings or quantified food group servings from the 3-day food record

735-xxxxxx-7 VDO

A., Petrov, A